Lead Product(s) : Nedaplatin
Therapeutic Area : Oncology
Study Phase : Phase II/ Phase III
Sponsor : Nestle Health Sciences SA
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 17, 2017
Lead Product(s) : Nedaplatin
Therapeutic Area : Oncology
Highest Development Status : Phase II/ Phase III
Sponsor : Nestle Health Sciences SA
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Nedaplatin
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 17, 2014
Lead Product(s) : Nedaplatin
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable